Resistance and co-resistance of metallo-beta-lactamase genes in diarrheal and urinary-tract pathogens in Bangladesh

Shanta, Ayasha Siddique and Islam, Nahidul and Al Asad, Mamun and Akter, Kakoli and Habib, Marnusa Binte and Hossain, Md. Jubayer and Hahar, Shamsun and Godman, Brian and Islam, Salequl (2024) Resistance and co-resistance of metallo-beta-lactamase genes in diarrheal and urinary-tract pathogens in Bangladesh. Microorganisms, 12 (8). 1589. ISSN 2076-2607 (https://doi.org/10.3390/microorganisms12081589)

[thumbnail of Shanta-etal-Microorganisms-2024-Resistance-and-co-resistance-of-metallo-beta-lactamase-genes]
Preview
 Text. Filename: Shanta-etal-Microorganisms-2024-Resistance-and-co-resistance-of-metallo-beta-lactamase-genes.pdf
Final Published Version
License: Creative Commons Attribution 4.0 logo
Download (1MB)| Preview

Abstract

Carbapenems are the antibiotics of choice for treating multidrug-resistant bacterial infections. Metallo-β-lactamases (MBLs) are carbapenemases capable of hydrolyzing nearly all therapeutically available beta-lactam antibiotics. Consequently, this research assessed the distribution of two MBL genes and three β-lactamases and their associated phenotypic resistance in diarrheal and urinary-tract infections (UTIs) to guide future policies. Samples were collected through a cross-sectional study, and β-lactamase genes were detected via PCR. A total of 228 diarrheal bacteria were isolated from 240 samples. The most predominant pathogens were Escherichia coli (32%) and Klebsiella spp. (7%). Phenotypic resistance to amoxicillin-clavulanic acid, aztreonam, cefuroxime, cefixime, cefepime, imipenem, meropenem, gentamicin, netilmicin, and amikacin was 50.4%, 65.6%, 66.8%, 80.5%, 54.4%, 41.6%, 25.7%, 41.2%, 37.2%, and 42.9%, respectively. A total of 142 UTI pathogens were identified from 150 urine samples. Klebsiella spp. (39%) and Escherichia coli (24%) were the major pathogens isolated. Phenotypic resistance to amoxicillin-clavulanic acid, aztreonam, cefuroxime, cefixime, cefepime, imipenem, meropenem, gentamicin, netilmicin, and amikacin was 93.7%, 75.0%, 91.5%, 93.7%, 88.0%, 72.5%, 13.6%, 44.4%, 71.1%, and 43%, respectively. Twenty-four diarrheal isolates carried blaNDM-1 or blaVIM genes. The overall MBL gene prevalence was 10.5%. Thirty-six UTI pathogens carried either blaNDM-1 or blaVIM genes (25.4%). Seven isolates carried both blaNDM-1 and blaVIM genes. MBL genes were strongly associated with phenotypic carbapenem and other β-lactam antibiotic resistance. blaOXA imparted significantly higher phenotypic resistance to β-lactam antibiotics. Active surveillance and stewardship programs are urgently needed to reduce carbapenem resistance in Bangladesh.

CORE (COnnecting REpositories)